Réaction #2186195

ord-f305d20863e0457e9526e40b8db01f2a

Équation de réaction

O=c1oc2cc(N3CCN(CCO)CC3)ccc2cc1-c1nc2ccccc2s1
3-benzothiazol-2-yl-7-[4-(2-hydroxy-ethyl)-piperazin-1-yl]-chromen-2-one
CCN(C(C)C)C(C)C
diisopropylethylamine
Cc1ccc(S(=O)(=O)Cl)cc1
tosyl chloride
COC(=O)Cc1nc2ccccc2s1
desired product
COC(=O)Cc1nc2ccccc2s1
Benzothiazol-2-yl-acetic acid methyl ester

Conditions de réaction

Température
0°CELSIUS
Conditions détaillées
See reaction.notes.procedure_details.

Traitement

  1. 1
    Autreto reach room temperature
  2. 2
    workup.STIRRINGAfter an additional two hours stirring
  3. 3
    Autrethe reaction mixture is evaporated
  4. 4
    workup.ADDITIONtreated with 0.2 mL tetrabutylammonium fluoride (1M in THF)
  5. 5
    workup.STIRRINGAfter stirring for 30 minutes
  6. 6
    Autrethe solution is evaporated

Mode opératoire

10 mg (0.025 mmol) 3-benzothiazol-2-yl-7-[4-(2-hydroxy-ethyl)-piperazin-1-yl]-chromen-2-one are dissolved in 3 mL dichloromethane with 2.5 mg (0.8 eq.) 4-dimethylaminopyridine and 0.013 mL (3 eq.) diisopropylethylamine, and cooled to 0° C. 5.7 mg (1.2 eq.) tosyl chloride are added and the reaction mixture stirred for one hour before being allowed to reach room temperature. After an additional two hours stirring, the reaction mixture is evaporated, the residue taken up in tetrahydrofurane and treated with 0.2 mL tetrabutylammonium fluoride (1M in THF). After stirring for 30 minutes, the solution is evaporated and the desired product obtained as a yellow powder.

Source

DOI: 10.6084/m9.figshare.5104873.v1Brevet: US07569337B2uspto-grants-2009_08